COMMERCIAL LICENSE AGREEMENTCommercial License Agreement • May 12th, 2023 • Oragenics Inc • Pharmaceutical preparations • Delaware
This COMMERCIAL LICENSE Agreement (the “Agreement”) is made and entered into effective as of February 21, 2023 (the “Effective Date”) by and between INSPIREVAX INC., a corporation incorporated in accordance with the federal laws of Canada, with a registered office at 46 rue de Saint-Tropez, Kirkland, Québec, Canada, H9J 2K6 (“Inspirevax”), and Oragenics, Inc., a Florida corporation having its principal place of business at 4902 Eisenhower Blvd., Suite 125, Tampa, FL 33634 (“Oragenics”). Inspirevax and Oragenics may be referred to herein individually as a “Party”, and collectively as the “Parties.”
